APGE - Company ID 0001974640
Apogee Therapeutics, Inc. has filed 262 public company documents between 2023 and 2026. The most frequent type is insider trade (88 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 4 | Insider trade | 6mo ago2025-12-23 | 2025-12-19 | View filing |
| 144 | Insider sale notice | 6mo ago2025-12-19 | - | View filing |
| 4 | Insider trade | 6mo ago2025-12-12 | 2025-12-10 | View filing |
| 4 | Insider trade | 7mo ago2025-12-05 | 2025-12-04 | View filing |
| 4 | Insider trade | 7mo ago2025-12-05 | 2025-12-04 | View filing |
| 4 | Insider trade | 7mo ago2025-12-05 | 2025-12-04 | View filing |
| 144 | Insider sale notice | 7mo ago2025-12-04 | - | View filing |
| 144 | Insider sale notice | 7mo ago2025-12-04 | - | View filing |
| 4 | Insider trade | 7mo ago2025-11-28 | 2025-11-25 | View filing |
| 144 | Insider sale notice | 7mo ago2025-11-25 | - | View filing |
| 144 | Insider sale notice | 7mo ago2025-11-14 | - | View filing |
| 4 | Insider trade | 7mo ago2025-11-14 | 2025-11-14 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 7mo ago2025-11-14 | - | View filing |
| 144 | Insider sale notice | 7mo ago2025-11-13 | - | View filing |
| 4 | Insider trade | 7mo ago2025-11-13 | 2025-11-11 | View filing |
| 4 | Insider trade | 7mo ago2025-11-13 | 2025-11-13 | View filing |
| 144 | Insider sale notice | 7mo ago2025-11-12 | - | View filing |
| 10-Q | Quarterly report | 8mo ago2025-11-10 | 2025-09-30 | View filing |
| 8-K | Major company event | 8mo ago2025-11-10 | 2025-11-10 | View filing |
| 4 | Insider trade | 8mo ago2025-11-07 | 2025-11-05 | View filing |
| 144 | Insider sale notice | 8mo ago2025-11-05 | - | View filing |
| 4 | Insider trade | 8mo ago2025-10-15 | 2025-10-10 | View filing |
| SCHEDULE 13D/A | SCHEDULE 13D/A | 8mo ago2025-10-14 | - | View filing |
| 8-K | Major company event | 9mo ago2025-10-10 | 2025-10-08 | View filing |
| 424B5 | Prospectus supplement | 9mo ago2025-10-10 | - | View filing |
| 424B5 | Prospectus supplement | 9mo ago2025-10-08 | - | View filing |
| 4 | Insider trade | 9mo ago2025-10-03 | 2025-10-01 | View filing |
| 4 | Insider trade | 10mo ago2025-09-05 | 2025-09-03 | View filing |
| 10-Q | Quarterly report | 11mo ago2025-08-11 | 2025-06-30 | View filing |
| 8-K | Major company event | 11mo ago2025-08-11 | 2025-08-11 | View filing |
| 4 | Insider trade | 11mo ago2025-08-08 | 2025-08-06 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 11mo ago2025-08-06 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 11mo ago2025-08-05 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 11mo ago2025-08-05 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 11mo ago2025-07-16 | - | View filing |
| 8-K | Major company event | 1y ago2025-07-07 | 2025-07-07 | View filing |
| 4 | Insider trade | 1y ago2025-07-03 | 2025-07-02 | View filing |
| 144 | Insider sale notice | 1y ago2025-07-02 | - | View filing |
| 8-K | Major company event | 1y ago2025-06-23 | 2025-06-17 | View filing |
| 4 | Insider trade | 1y ago2025-06-20 | 2025-06-17 | View filing |
| 4 | Insider trade | 1y ago2025-06-20 | 2025-06-17 | View filing |
| 4 | Insider trade | 1y ago2025-06-20 | 2025-06-17 | View filing |
| 4 | Insider trade | 1y ago2025-06-20 | 2025-06-17 | View filing |
| 4 | Insider trade | 1y ago2025-06-20 | 2025-06-17 | View filing |
| 4 | Insider trade | 1y ago2025-06-20 | 2025-06-17 | View filing |
| 4 | Insider trade | 1y ago2025-06-20 | 2025-06-17 | View filing |
| 4 | Insider trade | 1y ago2025-06-06 | 2025-06-04 | View filing |
| 8-K | Major company event | 1y ago2025-05-12 | 2025-05-12 | View filing |
| 10-Q | Quarterly report | 1y ago2025-05-12 | 2025-03-31 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-05-12 | - | View filing |